This compound is a nitrosamine impurity standard used in pharmaceutical quality control. It is identified as this compound, a structural analogue relevant to the analysis of fluoxetine impurities.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2659259-65-9
4-chloro-2-(furan-2-ylmethyl(nitroso)amino)-5-sulfamoylbenzoic acid
pharmaceutical intermediate
2-Nitrosooctahydrocyclopenta[c]pyrrole
pharmaceutical intermediate
1H-Indole, 1-nitroso-
pharmaceutical intermediate
N-tert-Butyl-N-{3-[(6,7-dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy]-2-hydroxypropyl}nitrous amide
pharmaceutical intermediate
3-Chloro-6-methyl-dibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide
pharmaceutical intermediate
3,11-Dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide
pharmaceutical intermediate
2-Oxazolidinone, 4,4-dimethyl-
pharmaceutical intermediate
N4-Benzoylcytosine
pharmaceutical intermediate
N-(3-hydroxy-3-phenylpropyl)-N-methylnitrous amide
PBZDQZIBWYIGIZ-UHFFFAOYSA-N
CN(CCC(C1=CC=CC=C1)O)N=O
—